Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization
View/ Open
1810.full.pdf (2.542Mb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Ramsauer, Markus
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1242/jcs.003533Metadata
Show full item recordCitation
Ramsauer, M., and P. A. D’Amore. 2007. “Contextual Role for Angiopoietins and TGFbeta1 in Blood Vessel Stabilization.” Journal of Cell Science 120 (10) (May 14): 1810–1817. doi:10.1242/jcs.003533.Abstract
We used a 3D in-vitro model of angiogenesis to investigate the effects of different growth factors on vessel formation and stabilization in vitro. Vascular endothelial growth factor (VEGF) was the only factor that induced the formation, elongation and sprouting of capillary-like structures (CLS) by bovine retinal capillary endothelial cells (BREC), an effect that was dose-dependent and saturable. Basic fibroblast growth factor 2 (FGF2) enhanced capillary formation in the presence of VEGF, leading to a more complex network of CLS and a higher rate of BrdU incorporation than VEGF alone, indicating that whereas VEGF acts as a morphogen, FGF2 is primarily a mitogen. Addition of transforming growth factor β1 (TGFβ1) to the 3D assay along with VEGF and FGF2, reduced tube formation in a dose-dependent manner. When added at the time of cell plating TGFβ1 completely suppressed formation of VEGF/FGF2-stimulated CLS. Angiopoietin 1 (Ang1) prevented regression of the TGFβ1-induced CLS, an effect that was blocked by angiopoietin 2 (Ang2), but required the continuous presence of VEGF.Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:35059700
Collections
- HMS Scholarly Articles [17842]
Contact administrator regarding this item (to report mistakes or request changes)
Comments made during the workflow steps
cat.complete